Prior to joining Apollo, Sasidhar held various roles at Cleveland Clinic, including President of Cleveland Clinic Tradition Hospital
Funding from the Series B round will propel the advancement of the company's pipeline through multiple stages of clinical development
This is the second time the firm has laid off employees. Pristyn had, in March last year, reportedly laid off 45 employees due to poor performance
Scientists on Tuesday announced that they have sequenced genomes of 10,000 Indians from diverse communities to create a database that could lead to gene-based remedies, with Union Science and Technology Minister Jitendra Singh calling it a watershed moment for science in India. Addressing a function in the national capital, Singh said genome study or sequencing is going to determine the future healthcare strategies across the world, both therapeutically and prophylactically. He said there is a pressing need for finding Indian solutions to Indian problems as the country emerges as a frontline nation in the comity of scientifically-advanced countries. Singh lauded the Department of Biotechnology for the ambitious goal to identify and catalogue the genetic variations of diverse Indian populations by sequencing the whole genome of 10,000 healthy individuals from 99 communities, representing all major linguistic and social groups, across the country. The Indian population of 1.3 billion
More than 1 billion people live in areas endemic for leishmaniasis or Kala Azar and are at risk of infection
India is its largest talent hub; comprises 75% of company's total workforce
Shiv Rao, CEO of Abridge and also a practicing cardiologist, said the company plans to use the fresh funding for hiring as well as acquiring and training purpose-built medical AI models
Entero's weak listing follows a lukewarm response to its Rs 1,600-crore IPO. The maiden share sale had garnered just 1.5 times subscription
Yatharth Hospital added that the bed capacity will be expanded to 200 to 220 beds post acquisition
Max Healthcare Institute on Friday said it has acquired Nagpur-based Alexis Multi-Speciality Hospital Pvt Ltd for Rs 412 crore. The 200-bed hospital is set up on a land parcel of 2-acre at Mankapur, north of Nagpur. The facility has potential to increase its bed capacity from 200 operational beds to 340 beds after necessary regulatory approvals. "The acquisition of Alexis Hospital is in line with our vision to expand our footprint in tier-2 cities with abundance of clinical talent and developed private healthcare infrastructure," Max Healthcare Institute Chairman and Managing Director Abhay Soi said. Alexis Hospital acquisition will strengthen company's presence in Maharashtra region, he added. Shares of Max Healthcare were trading at a loss of 0.42 per cent at Rs 866.4 apiece on the BSE.
Healthcare products distributor Entero Healthcare Solutions has collected Rs 716 crore from anchor investors. The company has allotted a total of 56.95 lakh equity shares to 25 funds at Rs 1,258 a piece, which is also the upper end of the price band, according to a circular uploaded on BSE's website late on Thursday. The anchor book saw participation from investors, including the Capital Group, Government of Singapore, Monetary Authority of Singapore, Amundi Funds New Silk Road, Societe Generale, Morgan Stanley Asia (Singapore) Pte, Goldman Sachs (Singapore) Pte, and Copthall Mauritius Investment Ltd. Additionally, Bajaj Allianz Life Insurance Company, SBI General Insurance, and Jupiter India Fund participated in the anchor round. The issue, with a price band of Rs 1,195-1,258 per share, opened for public subscription on Friday. It will close on February 13. The Rs 1,600 crore IPO is a combination of a fresh issue of equity shares worth up to Rs 1,000 crore and an Offer For Sale (
In FY23, Entero Healthcare reported Rs 33,00.20 crore in revenue from operations with a gross profit of Rs 268.34 crore
With this strategic acquisition, Thyrocare will expand its footprint in the pre-policy medical check-up segment for the insurance market
On a sequential basis, the company exhibited a 5.63 per cent decline in revenue along with PAT, which declined by 23.41 per cent
The October-December quarter encompasses the tail end of the monsoon as well as winter, which brings with them ailments such as influenza and stomach flu
Revenue and margins to remain healthy next financial year, too
For the Indian business in Q3 FY24, the revenue stood at Rs 1,180 crore Y-o-Y with a growth of 5 per cent and a sequential decline of 1 per cent
Demand will be for data scientists, developers and cybersecurity specialists, it says
Neelesh Surana expresses concerns over the quality of rally in certain smallcap pockets
Interim budget 2024: Here's what the experts of the real estate sector expect from the Centre